VIDAS/miniVIDAS: Healthcare

Designed to Last

VIDAS® and miniVIDAS® instruments are multiparametric immunoassay systems designed to help provide better care and the most accurate laboratory results.   

Save time with stat results, close patient cases and free up beds quicker. Save resources by eliminating unnecessary diagnostic tests. Identify and treat patients quickly. Initiate the targeted treatment.

Take control with on-site immunoassay testing capabilities from bioMérieux's Physician’s Office Laboratory suite. VIDAS and miniVIDAS deliver faster more accurate results and profits to your bottom line. In a time where HMOs, capitation and Medicare/Medicaid are constantly chipping away at physicians' businesses, you can now regain control of your patient and financial outcomes, while adding a profit center.

 

USES

  • For Clinical and Physician’s Office Laboratories
  • For Clinicians and Administrators

FEATURES AND BENEFITS

VIDAS is an automated, multiparametric immunoassay testing system. This uniquely designed testing device stores the calibration in the analyzer's memory, thus optimizing the cost-per-patient result. Plus, with its ready-to-use reagents, minimum maintenance, ease of use and uni/bi-directional interface, labor cost is also optimized. Automation and kinetic assay reactions yield rapid turnaround time.

The VIDAS® system allows for a flexible work routine with:

  • a sectioned architecture (5 sections of 6 tests each)
  • an add-on modular system
  • more efficient workflow
  • batch testing (up to 100 tests/2 hr.)
  • single sample testing
  • STAT capability
  • multiparametric testing
    • All VIDAS assays are single-dose format assays
    • Everything included in one kit
    • No reagent preparation – just load and go

Easy to Use:

  • Always ready with no startup and minimal maintenance
  • Ready-to-use reagents – just load and go

Cost Effective:

  • Single test reaction strip
  • Batch or multiple assay testing

Reliable:

  • Reliable system with MTBF* > 1,000 days
    *Mean Time Between Failure

miniVIDAS® is a compact version of the VIDAS® system with a built-in computer, keyboard and printer. Two independent sections each accept six tests and can process up to 12 samples simultaneously.

These automated immunoassay tests are reliable and economic. It uses ELFA (Enzyme Linked Fluorescent Assay) technology, has no carryover risks, requires a one-point recalibration once every 14 or 28 days depending on the assay and optimizes the cost per patient for batch or single sample testing. In addition, the menu of available assays is constantly growing.


Disclaimer: All VIDAS instruments and assays are to be run by laboratory personnel in a laboratory certified under CLIA or by a CLIA approved State laboratory program.  All personnel tasked with operating the VIDAS systems should be qualified and undergo a yearly competency assessment as defined in 42 CFR 493 subpart M “Personnel for Nonwaived Tests."

VIDAS / MINIVIDAS: HEALTHCARE FEATURES & SPECS

The VIDAS® immunoassay testing system uses a single-dose, ready-to-use reagent strip system

  • The SPR® (Solid Phase Receptacle) is coated with antigens or antibodies. 
  • The Strip contains all the reagents required for the reaction. 

The SPR acts as a pipetting and reagent transfer device. At each stage of the reaction, it aspirates the reagents in and out. This original concept prevents any inter-reagent or inter-sample contamination during immunoassay tests. In addition, the absence of tubing, syringes and needles reduces system maintenance to a minimum. (show picture)

The VIDAS system uses the ELFA assay principle, combining the ELISA test method with a final fluorescent reading. This technology ensures excellent result sensitivity and specificity.

Physical Features

Dimensions:

 

Vidas Blue

Vidas

 

Instrument packed

Instrument Alone

Instrument Packed

Instrument Alone

Height

59 cm (23 1/4")

45 cm (17 5/9")

58.2 cm (23")

44.4 cm (max.) 

(17 1/2")

Width

110 cm (43 1/3")

88 cm (34 1/2")

99 cm (39")

84.7y cm (33 1/3")

Depth

66 cm (26"

55 cm (21 5/8")

67.5 cm (26 5/8")

52.4 cm (20 5/8"_

Space Requirements:

 

 Vidas Blue

Vidas

Height

  65 cm (25 5/8")

 65 cm (25 5/8")

Width

  150 cm (59")

 150 cm (59")

Depth

  90 cm (35 1/2")

 90 cm (35 1/2")

The instrument must be placed on a flat surface with a maximum horizontality defect of 5".

Weight:

 

Vidas Blue

Vidas

 

Instrument packed

Instrument Alone

Instrument Packed

Instrument Alone

Mass

75 kg (165 1/3 lbs)

65 kg (143 1/2 lbs)

71 kg (156 1/2 lbs)

61 kg (134 1/2 lbs)

Sound level: 59 dBA

VIDAS® SPECIFICATIONS

Height: 23 inches (58 cm)
Width: 41.5 inches (105 cm)
Depth: 21.75 inches (68 cm)
Weight: 143 lbs (65 kg)

Stand-alone PC with printer, monitor, keyboard, and mouse (not included in listed dimensions)

Electrical requirements:

  • Voltage: 100-240 VAC
  • Electrical consumption: 3 - 1.2 A
  • Frequency: 50-60Hz
  • Power: 280 VA maximum
  • Heat emission: approximately 921 BTU/hr

Productivity:

  • Optimized cost per patient result
    • Uniquely designed testing device
    • Calibration stored in the analyzer's memory
  • Optimization of labor
    • Ready-to-use reagents
    • Minimum maintenance
    • Ease of use
    • Uni- or bidirectional interface to LIS
  • Rapid Results
    • Kinetic reactions
    • Automated
    • Efficient workflow

Flexibility:

  • Flexible work routine
  • "Sectioned" architecture – 5 sections, 6 tests each (30 total available)
  • "Add-on" modular system
  • Batch or single testing
  • STAT testing
  • Multiparametric testing
  • Load and Go

Quality:

  • Automation
  • No carryover contamination
  • Fluorescence reading
  • Ready-to-use, bar-code-labeled reagents
  • On-board QC program

MINIVIDAS® SPECIFICATIONS

Weight: 88 lbs (40 kg)

Integrated computer screen, keyboard and printer

Electrical requirements:

  • Voltage: 100-240 VAC
  • Electrical consumption: 1.5 – 0.8 A
  • Frequency: 50-60Hz
  • Power: 150 Watts
  • Heat emission: approximately 512 Btu/hr

Productivity:

  • Optimized cost per patient result
    • Uniquely designed testing device
    • Calibration stored in the analyzer's memory
  • Optimization of labor
    • Ready-to-use, single-dose reagents (reagent strip and SPR®)
    • Minimum maintenance
    • Ease of use
    • Uni- or bidirectional interface to LIS
  • Rapid Results
    • Kinetic reactions
    • Automated
    • Efficient workflow

Flexibility:

  • Flexible work routine
  • "Sectioned" architecture – 5 sections, 6 tests each (30 total available)
  • "Add-on" modular system
  • Batch or single testing
  • STAT testing
  • Multiparametric testing
  • Load and Go

Quality:

  • Automation
  • No carryover contamination
  • Fluorescence reading
  • Ready-to-use, bar-code-labeled reagents
  • On-board QC program 

Downloads


Disclaimer: All VIDAS instruments and assays are to be run by laboratory personnel in a laboratory certified under CLIA or by a CLIA approved State laboratory program.  All personnel tasked with operating the VIDAS systems should be qualified and undergo a yearly competency assessment as defined in 42 CFR 493 subpart M “Personnel for Nonwaived Tests."

VIDAS / MINIVIDAS: HEALTHCARE USES

For Clinical and Physician’s Office Laboratories:

  • Immunoassay system for antibody and antigen detection
    • Infectious diseases
    • Cardiac markers
    • Reproductive/fertility markers
    • Thyroid markers
    • Cancer markers
    • Specialty biomarkers
  • Uni/bi-directional interfacing with information systems 

For Clinicians and Administrators:

  • Compact, cost-efficient immunoassay platform
  • ELISA technology for enhanced specificity and sensitivity
  • Sepsis risk stratification and management
  • Exclusion of pulmonary embolism (PE) and deep vein thrombosis (DVT)
  • Testing for C. difficile Toxin A & B
  • Cancer monitoring
  • Thyroid monitoring
  • Reproductive/Fertility monitoring
  • Emergency triage
  • Cardiac detection and diagnosis
  • Infectious disease immunity status 

Disclaimer: All VIDAS instruments and assays are to be run by laboratory personnel in a laboratory certified under CLIA or by a CLIA approved State laboratory program.  All personnel tasked with operating the VIDAS systems should be qualified and undergo a yearly competency assessment as defined in 42 CFR 493 subpart M “Personnel for Nonwaived Tests."

VIDAS / MINIVIDAS: HEALTHCARE REAGENTS

Reagents for VIDAS® and miniVIDAS® instruments are available for the following applications. Click the heading to view the full list.

Clinical Laboratories

Clinicians and Administrators

*NEW: VIDAS TOXO IgG Avidity Assay Test

Clinical Laboratories

Specialty biomarkers

  • VIDAS® B·R·A·H·M·S® PCT Brochure – Diagnosis of bacterial infections and sepsis; rapid procalcitonin assay used with critically ill patients to assess risk for progression to severe sepsis and septic shock

Infectious disease

Cardiac assays

Coagulation

Reproductive hormones

Clinicians and Administrators

Specialty biomarkers

Infectious disease

Cardiac assays

Reproductive hormones

VIDAS® D-Dimer Exclusions™

  • The most referenced test for the exclusion of Venous Thromboembolism (VTE)
  • A proven ELISA technique
  • Expert validation in extensive prospective management clinical studies
  • First FDA cleared assay for exclusion of Deep Vein Thrombosis (DVT) and Pulmonary Embolism (PE) for outpatients with signs and symptoms of DVT and PE
  • Rapid turn around time to support emergency medicine needs
  • Upcoming webinar D-Dimer Testing: New CLSI Guidelines and Implications for Your Lab

Just One Test. A Clear Answer. The Right Choice

>> Learn more about Vidas D-Dimer Exclusion

VIDAS® B·R·A·H·M·S® PCT

What if you had an extra piece of information to manage bacterial infections?

In its early phase, bacterial infections and sepsis can be difficult to distinguish from non-bacterial infectious and/or inflammatory conditions. Moreover, assessing the progression of bacterial infection is sometimes a challenge. As a consequence, it may be difficult to make the appropriate clinical decision for individual patients.

PROCALCITONIN: the “extra piece” which can make the difference
Procalcitonin (PCT) is often increased during systemic bacterial infection and sepsis. This biomarker is now being recognized as a useful tool in the diagnostic process. It has been shown that PCT can contribute to optimization of antibiotic therapy and monitor treatment duration1.

VIDAS B·R·A·H·M·S PCT is an innovative procalcitonin assay. This assay is performed on the VIDAS system, which is fully adapted for emergency or stat conditions where rapid turnaround time is important.

What is Sepsis?

Definitions for the terms “SIRS”, “sepsis”, “severe sepsis” or “septic shock” have been proposed by the ACCP/SCCM consensus conference in 1992, and are now widely used (see table below 1).1

Clinical need for earlier detection of sepsis
Early detection and specific clinical intervention has been shown to be crucial for the improved outcome of patients with sepsis. However, sepsis can be difficult to distinguish from other, non-infections conditions in critically ill patients with clinical signs of acute inflammation and negative microbiological results. Therefore, in the early phase of the disease process it may be difficult to decide on the appropriate therapeutic measures for the individual patient.

Additional specific information may be helpful to increase the accuracy of sepsis diagnosis at an early stage. A parameter which fulfills these demands to a high degree is procalcitonin.

Fast and highly specific PCT increase in bacterial infection and sepsis One major advantage of PCT compared to other parameters is its early and highly specific increase in response to severe systemic bacterial infections and sepsis.2,3 Therefore, in septic conditions, increased PCT levels can be observed 3-6 hours after an infectious challenge.

PCT levels are usually low in viral infections, chronic inflammatory disorders or autoimmune processes. PCT levels in sepsis are generally greater than 0.5-2 ng/mL and often reach values between 10 and 100 ng/mL, or considerably higher in individual cases, thereby enabling diagnostic differentiation between these various clinical conditions and a severe bacterial infection (sepsis) (Figure 1).

1. Bone RC, Balk RA, Cerra FB, Dellinger RP, Fein AM, Knaus WA, Schein RM, Sibbald WJ. Definitions for sepsis and organ failure and guidelines for the use of innovative therapies in sepsis. The ACCP/SCCM Consensus Conference Committee. American College of Chest Physicians/Society of Critical Care Medicine. Chest 1992; 101: 1644-55.
2. Harbarth S, Holeckova K, Froidevaux C, Pittet D, Ricou B, Grau GE, Vadas L, Pugin J; Geneva Sepsis Network. Diagnostic value of procalcitonin, interleukin-6, and interleukin-8 in critically ill patients admitted with suspected sepsis. Am J Respir Crit Care Med. 2001; 164: 396-402.
3. Muller B, Becker KL, Schachinger H, Rickenbacher PR, Huber PR, Zimmerli W, Ritz R. Crit Care Med. 2000; 28: 977-83. Calcitonin precursors are reliable markers of sepsis in a medical intensive care unit.

What is PCT?

PCT is the prohormone of calcitonin (CT). Whereas CT is secreted by the C-cells of the thyroid after hormonal stimulation, PCT can be produced by numerous cell types and organs after proinflammatory stimulation, especially when caused by bacterial challenge.1

In healthy people, plasma PCT concentrations are found to be below 0.05 ng/ml, but can increase up to 1,000 ng/ml in patients with severe sepsis or septic shock.

Elevated PCT levels indicate bacterial infection accompanies by a systemic inflammatory reaction.

Localized infections do not generally cause circulating PCT increases. Slightly elevated PCT concentrations are observed in bacterial infections with minor systemic inflammatory response.

Very high values have been observed during acute disease conditions with severe systemic reactions to infection, in cases of severe sepsis or septic shock.

1. Christ-Crain M, Müller B. Procalcitonin in bacterial infections – hype, hope or more or less? Swiss Med Wkly 2005; 135: 451-60.

Visit Sepsis Know From Day One and listen to our podcast series, an educational series that provides a forum for scientific exchange and the sharing of experiences to help in the understanding and management of patients suspected of having sepsis.

VIDAS® NT-PROBNP

  • An effective tool to improve the diagnosis of heart failure
  • Wide range of detection limits
  • Rapid turn around time to support emergency medicine needs

VIDAS® TROPONIN I ULTRA

  • For patients arriving at the Emergency Department with chest pain
  • One of the first assays in the market to be traceable to the Troponin I certified reference (SRM 2921)
  • High clinical sensitivity at the 99th percentile (<0.01 μg/l) for early detection of myocardial infarction (MI)
  • Rapid turn around time to support emergency medicine needs

VIDAS® TUMOR MARKERS PANEL

  • The VIDAS range of tumor markers offers you a rapid, automated and reliable solution to meet all your clinicians' main requirements.
  • Sensitivity levels that ensure you obtain reliable results, even at low concentrations
  • The level of quality for VIDAS tests is regularly checked through external quality control surveys
  • VIDAS continuously performs a large number of self-tests to ensure a consistent level of quality
  • Our Equimolar TPSA assay is calibrated against the STANDFORD standard

VIDAS® C. DIFFICILE TOXINS A & B

  • Identify and treat infected patients quickly
  • Initiate prompt containment procedures
  • Avoid unnecessary patient isolation, particularly for elderly patients

VIDAS® LYME IGG/IGM

Especially during summer months, when patients are most vulnerable and concerned about Lyme Disease:

  • Is your laboratory providing quick answers?
  • Are you wasting too much time with multi-step laborious procedures?
  • Are you just waiting for results from your reference labs?

VIDAS® Lyme IgG/IgM can help you provide quick answers and improve your work flow and turn-around time.

VIDAS® Lyme IgG/IgM 30298-011

  • Results in 35 minutes
  • Automated assay
  • All reagents, calibrators, and controls are provided in the assay kit
  • Most reported assay in Lyme CAP survey (TTD-B 2010)

Disclaimer: All VIDAS instruments and assays are to be run by laboratory personnel in a laboratory certified under CLIA or by a CLIA approved State laboratory program.  All personnel tasked with operating the VIDAS systems should be qualified and undergo a yearly competency assessment as defined in 42 CFR 493 subpart M “Personnel for Nonwaived Tests."

VIDAS / MINIVIDAS: HEALTHCARE PUBLICATIONS

Procalcitonin:

Jo Bean, BS, MT(ASCP) and Pamela Pound, BS, MT(ASCP) SH. Fighting bacterial sepsis. Advance for Administrators of the Laboratory. Dec. 08

Using procalcitonin to diagnose sepsis and the potential for improved antibiotic stewardship.(MRSA). Medical Laboratory Observer. November 1, 2008. Faix, James D.

Procalcitonin increase in early identification of critically ill patients at high risk of mortality. Critical Care Medicine. 34(10):2596-2602, October 2006. Jensen, Jens Ulrik MD; Heslet, Lars MD, MDsc; Jensen, Tom Hartvig MD; Espersen, Kurt MD, PhD; Steffensen, Peter MSc; Tvede, Michael MD

Evaluation of the VIDAS Clostridium difficile Toxin A&B Assay Clinical Performance Compared to the Cellular Cytotoxicity and Meridian Premier Toxins A&B Assays and Assessment of the Assay’s Limit of Detection, Cross- Reactivity and Interference Characteristics

D-Dimer:

Stein P, Woodward P, Weg J, et al. Diagnostic Pathways in Acute Pulmonary Embolism: Recommendations of the PIOPED II Investigators. Am J Med (2006) 119, 1048-1055.

High Imprecision of a Point-of-Care D-Dimer Test Limits Its Utility for Reliable Exclusion of Venous Thromboembolism


Disclaimer: All VIDAS instruments and assays are to be run by laboratory personnel in a laboratory certified under CLIA or by a CLIA approved State laboratory program.  All personnel tasked with operating the VIDAS systems should be qualified and undergo a yearly competency assessment as defined in 42 CFR 493 subpart M “Personnel for Nonwaived Tests."

VIDAS / MINIVIDAS: HEALTHCARE PRODUCT DEMOS

VIDAS® D-Dimer Exclusion™ Product Demo

VIDAS® E. Coli O157 (Including H7) Product Demo


Disclaimer: All VIDAS instruments and assays are to be run by laboratory personnel in a laboratory certified under CLIA or by a CLIA approved State laboratory program.  All personnel tasked with operating the VIDAS systems should be qualified and undergo a yearly competency assessment as defined in 42 CFR 493 subpart M “Personnel for Nonwaived Tests."

Pioneering diagnostics